-
Featured
Proving Efficacy of Two Non-Drug Therapies for Hypertension
Research at the Massachusetts General Hospital Heart Center proves the effectiveness of the relaxation response and renal denervation to control high blood pressure.
-
Review: Cardiometabolic–Renal Comorbidities in Gout
Hyon K. Choi, MD, Chio Yokose, MD, MS, and Natalie McCormick, PhD, of the Division of Rheumatology, Allergy and Immunology, suggest pharmacologic agents that can both lower urate levels in patients with gout and treat common cardiometabolic-renal comorbidities of the disease.
-
Bone Marrow Vascular Pathologies Augment Supply of Leukocytes Implicated in CVD
Researchers from the Center for Systems Biology at Massachusetts General Hospital and colleagues address how three heart disease milestones—hypertension, atherosclerosis and myocardial infarction—impair the bone marrow's vascular health, suggesting a new direction for development of cardiovascular disease therapies.
-
AI Identifies Links Between Retinal Vascular Patterns and Risk of Cardiometabolic, Ocular Diseases
Measurements of retinal vascular density and branching, obtained from fundus photographs by convolutional neural networks at Massachusetts General Hospital, may be clinically useful as biomarkers of cardiometabolic disease severity and for predicting future risk of ocular diseases.
-
Using Renal Denervation to Treat Hypertension
Massachusetts General Hospital is one of few sites worldwide participating in research exploring the efficacy and safety of renal denervation to treat hypertension.
-
Age Influences the Effect of Risk Factors on Development of Heart Failure
Traditional risk factors have greater discriminatory value in predicting new onset of heart failure in younger adults than in older people, according to a pooled population-based cohort study by Samantha M.A. Paniagua, Sanjiv J. Shah, MD, and Jennifer E. Ho, MD, of the Cardiovascular Research Center, and colleagues.
Hypertension Contributors
-
Alison S. Witkin, MD
Associate Director, Pulmonary Hypertension and Thromboendarterectomy Program, Massachusetts General Hospital
Recent Article
Studies Work to Improve Pulmonary Hypertension and HHT Care
-
Gregory D. Lewis, MD
Section Head, Heart Failure, Director, Cardiopulmonary Exercise Testing Laboratory, Medical Director, Cardiology ICU and Mechanical Circulatory Support Program
Recent Article
Physical Activity Associated with Better Cardiovascular Fitness Regardless of Age, Health Status
-
Jennifer E. Ho, MD
Cardiologist, Heart Failure and Transplantation Program, Assistant Professor of Medicine, Harvard Medical School
Recent Article
Greater COVID-19 Severity in Men May Be Due to Greater Inflammatory Response
-
Josanna M. Rodriguez-Lopez, MD
Director, HHT Center, Director, Pulmonary Hypertension and Thromboendarterectomy Program
Recent Article
Studies Work to Improve Pulmonary Hypertension and HHT Care
-
Pradeep Natarajan, MD, MMSc
Director, Preventive Cardiology, Associate Professor of Medicine, Harvard Medical School
Recent Article
AI Identifies Links Between Retinal Vascular Patterns and Risk of Cardiometabolic, Ocular Diseases
-
Randall Mark Zusman, MD
Director, Division of Hypertension
Recent Article
Using Renal Denervation to Treat Hypertension
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.